Global Heart Failure Therapeutics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Heart Failure Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Heart Failure Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Heart Failure Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Heart Failure Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Heart Failure Therapeutics market, reaching US$ million by the year 2028. As for the Europe Heart Failure Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Heart Failure Therapeutics players cover Bayer, Cynokinetics, Les Laboratoires Servier, and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Heart Failure Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Heart Failure Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Heart Failure Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Heart Failure Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Heart Failure Therapeutics market, reaching US$ million by the year 2028. As for the Europe Heart Failure Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Heart Failure Therapeutics players cover Bayer, Cynokinetics, Les Laboratoires Servier, and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Diagnosis
- Prognosis
- Treatment Options and Treatment Algorithm
- Hospital
- Clinic
- Medical Research Organization
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Cynokinetics
- Les Laboratoires Servier
- Merck & Co.
- Novartis
- Procoralan
- Bristol-Myers Squibb Company
- Cardiorentis AG
- CVie Therapeutics Limited
- Orion Corporation
- PhaseBio Pharmaceuticals
- Market Segment by Product Type
- B-Blockers
- Calcium Channel Blockers
- Cardiac Glycosides
- Diuretics
- Morphine
- Vasodilators/Nitrates
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Heart Failure Therapeutics Market Size 2017-2028
2.1.2 Heart Failure Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Heart Failure Therapeutics Segment by Type
2.2.1 Diagnosis
2.2.2 Prognosis
2.2.3 Treatment Options and Treatment Algorithm
2.3 Heart Failure Therapeutics Market Size by Type
2.3.1 Heart Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Heart Failure Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Organization
2.5 Heart Failure Therapeutics Market Size by Application
2.5.1 Heart Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
3 HEART FAILURE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Heart Failure Therapeutics Market Size Market Share by Players
3.1.1 Global Heart Failure Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Heart Failure Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Heart Failure Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEART FAILURE THERAPEUTICS BY REGIONS
4.1 Heart Failure Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Heart Failure Therapeutics Market Size Growth (2017-2022)
4.3 APAC Heart Failure Therapeutics Market Size Growth (2017-2022)
4.4 Europe Heart Failure Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Heart Failure Therapeutics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Heart Failure Therapeutics Market Size by Country (2017-2022)
5.2 Americas Heart Failure Therapeutics Market Size by Type (2017-2022)
5.3 Americas Heart Failure Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heart Failure Therapeutics Market Size by Region (2017-2022)
6.2 APAC Heart Failure Therapeutics Market Size by Type (2017-2022)
6.3 APAC Heart Failure Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Heart Failure Therapeutics by Country (2017-2022)
7.2 Europe Heart Failure Therapeutics Market Size by Type (2017-2022)
7.3 Europe Heart Failure Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Heart Failure Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Heart Failure Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Heart Failure Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEART FAILURE THERAPEUTICS MARKET FORECAST
10.1 Global Heart Failure Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Heart Failure Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Heart Failure Therapeutics Forecast
10.1.3 APAC Heart Failure Therapeutics Forecast
10.1.4 Europe Heart Failure Therapeutics Forecast
10.1.5 Middle East & Africa Heart Failure Therapeutics Forecast
10.2 Americas Heart Failure Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Heart Failure Therapeutics Market Forecast
10.2.2 Canada Heart Failure Therapeutics Market Forecast
10.2.3 Mexico Heart Failure Therapeutics Market Forecast
10.2.4 Brazil Heart Failure Therapeutics Market Forecast
10.3 APAC Heart Failure Therapeutics Forecast by Region (2023-2028)
10.3.1 China Heart Failure Therapeutics Market Forecast
10.3.2 Japan Heart Failure Therapeutics Market Forecast
10.3.3 Korea Heart Failure Therapeutics Market Forecast
10.3.4 Southeast Asia Heart Failure Therapeutics Market Forecast
10.3.5 India Heart Failure Therapeutics Market Forecast
10.3.6 Australia Heart Failure Therapeutics Market Forecast
10.4 Europe Heart Failure Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Heart Failure Therapeutics Market Forecast
10.4.2 France Heart Failure Therapeutics Market Forecast
10.4.3 UK Heart Failure Therapeutics Market Forecast
10.4.4 Italy Heart Failure Therapeutics Market Forecast
10.4.5 Russia Heart Failure Therapeutics Market Forecast
10.5 Middle East & Africa Heart Failure Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Heart Failure Therapeutics Market Forecast
10.5.2 South Africa Heart Failure Therapeutics Market Forecast
10.5.3 Israel Heart Failure Therapeutics Market Forecast
10.5.4 Turkey Heart Failure Therapeutics Market Forecast
10.5.5 GCC Countries Heart Failure Therapeutics Market Forecast
10.6 Global Heart Failure Therapeutics Forecast by Type (2023-2028)
10.7 Global Heart Failure Therapeutics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Heart Failure Therapeutics Product Offered
11.1.3 Bayer Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Cynokinetics
11.2.1 Cynokinetics Company Information
11.2.2 Cynokinetics Heart Failure Therapeutics Product Offered
11.2.3 Cynokinetics Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cynokinetics Main Business Overview
11.2.5 Cynokinetics Latest Developments
11.3 Les Laboratoires Servier
11.3.1 Les Laboratoires Servier Company Information
11.3.2 Les Laboratoires Servier Heart Failure Therapeutics Product Offered
11.3.3 Les Laboratoires Servier Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Les Laboratoires Servier Main Business Overview
11.3.5 Les Laboratoires Servier Latest Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Company Information
11.4.2 Merck & Co. Heart Failure Therapeutics Product Offered
11.4.3 Merck & Co. Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck & Co. Main Business Overview
11.4.5 Merck & Co. Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Heart Failure Therapeutics Product Offered
11.5.3 Novartis Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Procoralan
11.6.1 Procoralan Company Information
11.6.2 Procoralan Heart Failure Therapeutics Product Offered
11.6.3 Procoralan Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Procoralan Main Business Overview
11.6.5 Procoralan Latest Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Information
11.7.2 Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Company Main Business Overview
11.7.5 Bristol-Myers Squibb Company Latest Developments
11.8 Cardiorentis AG
11.8.1 Cardiorentis AG Company Information
11.8.2 Cardiorentis AG Heart Failure Therapeutics Product Offered
11.8.3 Cardiorentis AG Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cardiorentis AG Main Business Overview
11.8.5 Cardiorentis AG Latest Developments
11.9 CVie Therapeutics Limited
11.9.1 CVie Therapeutics Limited Company Information
11.9.2 CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
11.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 CVie Therapeutics Limited Main Business Overview
11.9.5 CVie Therapeutics Limited Latest Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Heart Failure Therapeutics Product Offered
11.10.3 Orion Corporation Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Orion Corporation Main Business Overview
11.10.5 Orion Corporation Latest Developments
11.11 PhaseBio Pharmaceuticals
11.11.1 PhaseBio Pharmaceuticals Company Information
11.11.2 PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
11.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 PhaseBio Pharmaceuticals Main Business Overview
11.11.5 PhaseBio Pharmaceuticals Latest Developments
11.12 Market Segment by Product Type
11.12.1 Market Segment by Product Type Company Information
11.12.2 Market Segment by Product Type Heart Failure Therapeutics Product Offered
11.12.3 Market Segment by Product Type Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Market Segment by Product Type Main Business Overview
11.12.5 Market Segment by Product Type Latest Developments
11.13 B-Blockers
11.13.1 B-Blockers Company Information
11.13.2 B-Blockers Heart Failure Therapeutics Product Offered
11.13.3 B-Blockers Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 B-Blockers Main Business Overview
11.13.5 B-Blockers Latest Developments
11.14 Calcium Channel Blockers
11.14.1 Calcium Channel Blockers Company Information
11.14.2 Calcium Channel Blockers Heart Failure Therapeutics Product Offered
11.14.3 Calcium Channel Blockers Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Calcium Channel Blockers Main Business Overview
11.14.5 Calcium Channel Blockers Latest Developments
11.15 Cardiac Glycosides
11.15.1 Cardiac Glycosides Company Information
11.15.2 Cardiac Glycosides Heart Failure Therapeutics Product Offered
11.15.3 Cardiac Glycosides Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Cardiac Glycosides Main Business Overview
11.15.5 Cardiac Glycosides Latest Developments
11.16 Diuretics
11.16.1 Diuretics Company Information
11.16.2 Diuretics Heart Failure Therapeutics Product Offered
11.16.3 Diuretics Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Diuretics Main Business Overview
11.16.5 Diuretics Latest Developments
11.17 Morphine
11.17.1 Morphine Company Information
11.17.2 Morphine Heart Failure Therapeutics Product Offered
11.17.3 Morphine Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Morphine Main Business Overview
11.17.5 Morphine Latest Developments
11.18 Vasodilators/Nitrates
11.18.1 Vasodilators/Nitrates Company Information
11.18.2 Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
11.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Vasodilators/Nitrates Main Business Overview
11.18.5 Vasodilators/Nitrates Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Heart Failure Therapeutics Market Size 2017-2028
2.1.2 Heart Failure Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Heart Failure Therapeutics Segment by Type
2.2.1 Diagnosis
2.2.2 Prognosis
2.2.3 Treatment Options and Treatment Algorithm
2.3 Heart Failure Therapeutics Market Size by Type
2.3.1 Heart Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Heart Failure Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Organization
2.5 Heart Failure Therapeutics Market Size by Application
2.5.1 Heart Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
3 HEART FAILURE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Heart Failure Therapeutics Market Size Market Share by Players
3.1.1 Global Heart Failure Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Heart Failure Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Heart Failure Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEART FAILURE THERAPEUTICS BY REGIONS
4.1 Heart Failure Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Heart Failure Therapeutics Market Size Growth (2017-2022)
4.3 APAC Heart Failure Therapeutics Market Size Growth (2017-2022)
4.4 Europe Heart Failure Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Heart Failure Therapeutics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Heart Failure Therapeutics Market Size by Country (2017-2022)
5.2 Americas Heart Failure Therapeutics Market Size by Type (2017-2022)
5.3 Americas Heart Failure Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heart Failure Therapeutics Market Size by Region (2017-2022)
6.2 APAC Heart Failure Therapeutics Market Size by Type (2017-2022)
6.3 APAC Heart Failure Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Heart Failure Therapeutics by Country (2017-2022)
7.2 Europe Heart Failure Therapeutics Market Size by Type (2017-2022)
7.3 Europe Heart Failure Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Heart Failure Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Heart Failure Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Heart Failure Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEART FAILURE THERAPEUTICS MARKET FORECAST
10.1 Global Heart Failure Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Heart Failure Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Heart Failure Therapeutics Forecast
10.1.3 APAC Heart Failure Therapeutics Forecast
10.1.4 Europe Heart Failure Therapeutics Forecast
10.1.5 Middle East & Africa Heart Failure Therapeutics Forecast
10.2 Americas Heart Failure Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Heart Failure Therapeutics Market Forecast
10.2.2 Canada Heart Failure Therapeutics Market Forecast
10.2.3 Mexico Heart Failure Therapeutics Market Forecast
10.2.4 Brazil Heart Failure Therapeutics Market Forecast
10.3 APAC Heart Failure Therapeutics Forecast by Region (2023-2028)
10.3.1 China Heart Failure Therapeutics Market Forecast
10.3.2 Japan Heart Failure Therapeutics Market Forecast
10.3.3 Korea Heart Failure Therapeutics Market Forecast
10.3.4 Southeast Asia Heart Failure Therapeutics Market Forecast
10.3.5 India Heart Failure Therapeutics Market Forecast
10.3.6 Australia Heart Failure Therapeutics Market Forecast
10.4 Europe Heart Failure Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Heart Failure Therapeutics Market Forecast
10.4.2 France Heart Failure Therapeutics Market Forecast
10.4.3 UK Heart Failure Therapeutics Market Forecast
10.4.4 Italy Heart Failure Therapeutics Market Forecast
10.4.5 Russia Heart Failure Therapeutics Market Forecast
10.5 Middle East & Africa Heart Failure Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Heart Failure Therapeutics Market Forecast
10.5.2 South Africa Heart Failure Therapeutics Market Forecast
10.5.3 Israel Heart Failure Therapeutics Market Forecast
10.5.4 Turkey Heart Failure Therapeutics Market Forecast
10.5.5 GCC Countries Heart Failure Therapeutics Market Forecast
10.6 Global Heart Failure Therapeutics Forecast by Type (2023-2028)
10.7 Global Heart Failure Therapeutics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Heart Failure Therapeutics Product Offered
11.1.3 Bayer Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Cynokinetics
11.2.1 Cynokinetics Company Information
11.2.2 Cynokinetics Heart Failure Therapeutics Product Offered
11.2.3 Cynokinetics Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cynokinetics Main Business Overview
11.2.5 Cynokinetics Latest Developments
11.3 Les Laboratoires Servier
11.3.1 Les Laboratoires Servier Company Information
11.3.2 Les Laboratoires Servier Heart Failure Therapeutics Product Offered
11.3.3 Les Laboratoires Servier Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Les Laboratoires Servier Main Business Overview
11.3.5 Les Laboratoires Servier Latest Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Company Information
11.4.2 Merck & Co. Heart Failure Therapeutics Product Offered
11.4.3 Merck & Co. Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck & Co. Main Business Overview
11.4.5 Merck & Co. Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Heart Failure Therapeutics Product Offered
11.5.3 Novartis Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Procoralan
11.6.1 Procoralan Company Information
11.6.2 Procoralan Heart Failure Therapeutics Product Offered
11.6.3 Procoralan Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Procoralan Main Business Overview
11.6.5 Procoralan Latest Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Information
11.7.2 Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Company Main Business Overview
11.7.5 Bristol-Myers Squibb Company Latest Developments
11.8 Cardiorentis AG
11.8.1 Cardiorentis AG Company Information
11.8.2 Cardiorentis AG Heart Failure Therapeutics Product Offered
11.8.3 Cardiorentis AG Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cardiorentis AG Main Business Overview
11.8.5 Cardiorentis AG Latest Developments
11.9 CVie Therapeutics Limited
11.9.1 CVie Therapeutics Limited Company Information
11.9.2 CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
11.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 CVie Therapeutics Limited Main Business Overview
11.9.5 CVie Therapeutics Limited Latest Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Heart Failure Therapeutics Product Offered
11.10.3 Orion Corporation Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Orion Corporation Main Business Overview
11.10.5 Orion Corporation Latest Developments
11.11 PhaseBio Pharmaceuticals
11.11.1 PhaseBio Pharmaceuticals Company Information
11.11.2 PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
11.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 PhaseBio Pharmaceuticals Main Business Overview
11.11.5 PhaseBio Pharmaceuticals Latest Developments
11.12 Market Segment by Product Type
11.12.1 Market Segment by Product Type Company Information
11.12.2 Market Segment by Product Type Heart Failure Therapeutics Product Offered
11.12.3 Market Segment by Product Type Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Market Segment by Product Type Main Business Overview
11.12.5 Market Segment by Product Type Latest Developments
11.13 B-Blockers
11.13.1 B-Blockers Company Information
11.13.2 B-Blockers Heart Failure Therapeutics Product Offered
11.13.3 B-Blockers Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 B-Blockers Main Business Overview
11.13.5 B-Blockers Latest Developments
11.14 Calcium Channel Blockers
11.14.1 Calcium Channel Blockers Company Information
11.14.2 Calcium Channel Blockers Heart Failure Therapeutics Product Offered
11.14.3 Calcium Channel Blockers Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Calcium Channel Blockers Main Business Overview
11.14.5 Calcium Channel Blockers Latest Developments
11.15 Cardiac Glycosides
11.15.1 Cardiac Glycosides Company Information
11.15.2 Cardiac Glycosides Heart Failure Therapeutics Product Offered
11.15.3 Cardiac Glycosides Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Cardiac Glycosides Main Business Overview
11.15.5 Cardiac Glycosides Latest Developments
11.16 Diuretics
11.16.1 Diuretics Company Information
11.16.2 Diuretics Heart Failure Therapeutics Product Offered
11.16.3 Diuretics Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Diuretics Main Business Overview
11.16.5 Diuretics Latest Developments
11.17 Morphine
11.17.1 Morphine Company Information
11.17.2 Morphine Heart Failure Therapeutics Product Offered
11.17.3 Morphine Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Morphine Main Business Overview
11.17.5 Morphine Latest Developments
11.18 Vasodilators/Nitrates
11.18.1 Vasodilators/Nitrates Company Information
11.18.2 Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
11.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Vasodilators/Nitrates Main Business Overview
11.18.5 Vasodilators/Nitrates Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Heart Failure Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Prognosis
Table 4. Major Players of Treatment Options and Treatment Algorithm
Table 5. Heart Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Heart Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Heart Failure Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Heart Failure Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Heart Failure Therapeutics Key Players Head office and Products Offered
Table 14. Heart Failure Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Heart Failure Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Heart Failure Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Heart Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Heart Failure Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Heart Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Heart Failure Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Heart Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Heart Failure Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Heart Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Heart Failure Therapeutics
Table 44. Key Market Challenges & Risks of Heart Failure Therapeutics
Table 45. Key Industry Trends of Heart Failure Therapeutics
Table 46. Global Heart Failure Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Heart Failure Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Heart Failure Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Heart Failure Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Heart Failure Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Heart Failure Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Bayer Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 53. Bayer Heart Failure Therapeutics Product Offered
Table 54. Bayer Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Bayer Main Business
Table 56. Bayer Latest Developments
Table 57. Cynokinetics Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 58. Cynokinetics Heart Failure Therapeutics Product Offered
Table 59. Cynokinetics Main Business
Table 60. Cynokinetics Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Cynokinetics Latest Developments
Table 62. Les Laboratoires Servier Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 63. Les Laboratoires Servier Heart Failure Therapeutics Product Offered
Table 64. Les Laboratoires Servier Main Business
Table 65. Les Laboratoires Servier Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Les Laboratoires Servier Latest Developments
Table 67. Merck & Co. Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 68. Merck & Co. Heart Failure Therapeutics Product Offered
Table 69. Merck & Co. Main Business
Table 70. Merck & Co. Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Merck & Co. Latest Developments
Table 72. Novartis Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 73. Novartis Heart Failure Therapeutics Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Novartis Latest Developments
Table 77. Procoralan Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 78. Procoralan Heart Failure Therapeutics Product Offered
Table 79. Procoralan Main Business
Table 80. Procoralan Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Procoralan Latest Developments
Table 82. Bristol-Myers Squibb Company Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
Table 84. Bristol-Myers Squibb Company Main Business
Table 85. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol-Myers Squibb Company Latest Developments
Table 87. Cardiorentis AG Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 88. Cardiorentis AG Heart Failure Therapeutics Product Offered
Table 89. Cardiorentis AG Main Business
Table 90. Cardiorentis AG Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Cardiorentis AG Latest Developments
Table 92. CVie Therapeutics Limited Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 93. CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
Table 94. CVie Therapeutics Limited Main Business
Table 95. CVie Therapeutics Limited Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. CVie Therapeutics Limited Latest Developments
Table 97. Orion Corporation Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 98. Orion Corporation Heart Failure Therapeutics Product Offered
Table 99. Orion Corporation Main Business
Table 100. Orion Corporation Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Orion Corporation Latest Developments
Table 102. PhaseBio Pharmaceuticals Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 103. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
Table 104. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. PhaseBio Pharmaceuticals Main Business
Table 106. PhaseBio Pharmaceuticals Latest Developments
Table 107. Market Segment by Product Type Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 108. Market Segment by Product Type Heart Failure Therapeutics Product Offered
Table 109. Market Segment by Product Type Main Business
Table 110. Market Segment by Product Type Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Market Segment by Product Type Latest Developments
Table 112. B-Blockers Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 113. B-Blockers Heart Failure Therapeutics Product Offered
Table 114. B-Blockers Main Business
Table 115. B-Blockers Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. B-Blockers Latest Developments
Table 117. Calcium Channel Blockers Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 118. Calcium Channel Blockers Heart Failure Therapeutics Product Offered
Table 119. Calcium Channel Blockers Main Business
Table 120. Calcium Channel Blockers Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Calcium Channel Blockers Latest Developments
Table 122. Cardiac Glycosides Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 123. Cardiac Glycosides Heart Failure Therapeutics Product Offered
Table 124. Cardiac Glycosides Main Business
Table 125. Cardiac Glycosides Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Cardiac Glycosides Latest Developments
Table 127. Diuretics Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 128. Diuretics Heart Failure Therapeutics Product Offered
Table 129. Diuretics Main Business
Table 130. Diuretics Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Diuretics Latest Developments
Table 132. Morphine Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 133. Morphine Heart Failure Therapeutics Product Offered
Table 134. Morphine Main Business
Table 135. Morphine Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Morphine Latest Developments
Table 137. Vasodilators/Nitrates Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 138. Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
Table 139. Vasodilators/Nitrates Main Business
Table 140. Vasodilators/Nitrates Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. Vasodilators/Nitrates Latest Developments
Table 1. Heart Failure Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Prognosis
Table 4. Major Players of Treatment Options and Treatment Algorithm
Table 5. Heart Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Heart Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Heart Failure Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Heart Failure Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Heart Failure Therapeutics Key Players Head office and Products Offered
Table 14. Heart Failure Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Heart Failure Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Heart Failure Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Heart Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Heart Failure Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Heart Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Heart Failure Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Heart Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Heart Failure Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Heart Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Heart Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Heart Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Heart Failure Therapeutics
Table 44. Key Market Challenges & Risks of Heart Failure Therapeutics
Table 45. Key Industry Trends of Heart Failure Therapeutics
Table 46. Global Heart Failure Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Heart Failure Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Heart Failure Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Heart Failure Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Heart Failure Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Heart Failure Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Bayer Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 53. Bayer Heart Failure Therapeutics Product Offered
Table 54. Bayer Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Bayer Main Business
Table 56. Bayer Latest Developments
Table 57. Cynokinetics Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 58. Cynokinetics Heart Failure Therapeutics Product Offered
Table 59. Cynokinetics Main Business
Table 60. Cynokinetics Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Cynokinetics Latest Developments
Table 62. Les Laboratoires Servier Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 63. Les Laboratoires Servier Heart Failure Therapeutics Product Offered
Table 64. Les Laboratoires Servier Main Business
Table 65. Les Laboratoires Servier Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Les Laboratoires Servier Latest Developments
Table 67. Merck & Co. Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 68. Merck & Co. Heart Failure Therapeutics Product Offered
Table 69. Merck & Co. Main Business
Table 70. Merck & Co. Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Merck & Co. Latest Developments
Table 72. Novartis Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 73. Novartis Heart Failure Therapeutics Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Novartis Latest Developments
Table 77. Procoralan Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 78. Procoralan Heart Failure Therapeutics Product Offered
Table 79. Procoralan Main Business
Table 80. Procoralan Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Procoralan Latest Developments
Table 82. Bristol-Myers Squibb Company Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
Table 84. Bristol-Myers Squibb Company Main Business
Table 85. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol-Myers Squibb Company Latest Developments
Table 87. Cardiorentis AG Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 88. Cardiorentis AG Heart Failure Therapeutics Product Offered
Table 89. Cardiorentis AG Main Business
Table 90. Cardiorentis AG Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Cardiorentis AG Latest Developments
Table 92. CVie Therapeutics Limited Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 93. CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
Table 94. CVie Therapeutics Limited Main Business
Table 95. CVie Therapeutics Limited Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. CVie Therapeutics Limited Latest Developments
Table 97. Orion Corporation Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 98. Orion Corporation Heart Failure Therapeutics Product Offered
Table 99. Orion Corporation Main Business
Table 100. Orion Corporation Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Orion Corporation Latest Developments
Table 102. PhaseBio Pharmaceuticals Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 103. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
Table 104. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. PhaseBio Pharmaceuticals Main Business
Table 106. PhaseBio Pharmaceuticals Latest Developments
Table 107. Market Segment by Product Type Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 108. Market Segment by Product Type Heart Failure Therapeutics Product Offered
Table 109. Market Segment by Product Type Main Business
Table 110. Market Segment by Product Type Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Market Segment by Product Type Latest Developments
Table 112. B-Blockers Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 113. B-Blockers Heart Failure Therapeutics Product Offered
Table 114. B-Blockers Main Business
Table 115. B-Blockers Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. B-Blockers Latest Developments
Table 117. Calcium Channel Blockers Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 118. Calcium Channel Blockers Heart Failure Therapeutics Product Offered
Table 119. Calcium Channel Blockers Main Business
Table 120. Calcium Channel Blockers Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Calcium Channel Blockers Latest Developments
Table 122. Cardiac Glycosides Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 123. Cardiac Glycosides Heart Failure Therapeutics Product Offered
Table 124. Cardiac Glycosides Main Business
Table 125. Cardiac Glycosides Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Cardiac Glycosides Latest Developments
Table 127. Diuretics Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 128. Diuretics Heart Failure Therapeutics Product Offered
Table 129. Diuretics Main Business
Table 130. Diuretics Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Diuretics Latest Developments
Table 132. Morphine Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 133. Morphine Heart Failure Therapeutics Product Offered
Table 134. Morphine Main Business
Table 135. Morphine Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Morphine Latest Developments
Table 137. Vasodilators/Nitrates Details, Company Type, Heart Failure Therapeutics Area Served and Its Competitors
Table 138. Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
Table 139. Vasodilators/Nitrates Main Business
Table 140. Vasodilators/Nitrates Heart Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. Vasodilators/Nitrates Latest Developments
LIST OF FIGURES
Figure 1. Heart Failure Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Heart Failure Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 7. Heart Failure Therapeutics in Hospital
Figure 8. Global Heart Failure Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Heart Failure Therapeutics in Clinic
Figure 10. Global Heart Failure Therapeutics Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Heart Failure Therapeutics in Medical Research Organization
Figure 12. Global Heart Failure Therapeutics Market: Medical Research Organization (2017-2022) & ($ Millions)
Figure 13. Global Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Heart Failure Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Heart Failure Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Heart Failure Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Heart Failure Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Heart Failure Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Heart Failure Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 1. Heart Failure Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Heart Failure Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 7. Heart Failure Therapeutics in Hospital
Figure 8. Global Heart Failure Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Heart Failure Therapeutics in Clinic
Figure 10. Global Heart Failure Therapeutics Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Heart Failure Therapeutics in Medical Research Organization
Figure 12. Global Heart Failure Therapeutics Market: Medical Research Organization (2017-2022) & ($ Millions)
Figure 13. Global Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Heart Failure Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Heart Failure Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Heart Failure Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Heart Failure Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Heart Failure Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Heart Failure Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Heart Failure Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Heart Failure Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Heart Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Heart Failure Therapeutics Market Size 2023-2028 ($ Millions)
